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The effects of acute and chronic treatment with 
ethanol on transport of reducing equivalents into mi- 
tochondria via the malate-aspartate shuttle were stud- 
ied in perfused rat liver. The shuttle capacity was 
estimated from the decrease in rates of glucose produc- 
tion from the reduced substrate sorbitol caused by an 
increase in the NADH/NAD+ ratio in the cytosol due to 
metabolism of ethanol. The greater the capacity of the 
malate-aspartate shuttle, the smaller the inhibition of 
glucose synthesis by ethanol. Glucose synthesis was 
decreased about P-fold less in livers from fasted rats 
treated acutely 2.5 h earlier with ethanol than in un- 
treated controls. Chronic treatment with ethanol for 
3-5 weeks prevented completely the decrease in glu- 
cose synthesis from sorbitol due to ethanol oxidation. 
Rates of ethanol uptake were elevated significantly 
from 69 f 7 rmol/g/h in livers from control rats up to 
92 & 7 rmol/g/h in livers from SIAM rats. Similarly, 
rates of ethanol uptake were stimulated by chronic 
ethanol treatment from 71 & 6 to 222 f 15 pmol/g/h; 
this increase was largely sensitive to aminooxyacetate. 
Taken together, these data indicate that flux of reduc- 
ing equivalents over the malate-aspartate shuttle is 
increased by both acute and chronic treatment with 
ethanol and that movement of reducing equivalents 
from the cytosol into the mitochondria via the malate- 
aspartate shuttle is an important rate determinant in 
hepatic ethanol oxidation. 
oxalacetate is converted into aspartate and moves into the 
cytosol in exchange for glutamate. To complete the cycle, 
oxalacetate is regenerated in the cytosol from aspartate by 
transamination. 
The malate-aspartate shuttle has been difficult to study 
because essential intermediates are distributed in both the 
cytosol and mitochondria (2). Recently, a new method was 
developed to estimate the capacity of the malate-aspartate 
shuttle mechanism based on inhibition of gluconeogenesis 
from a reduced substrate such as sorbitol due to ethanol 
oxidation in the perfused liver (3). By increasing NADH in 
the cytosol, ethanol increases competition for the movement 
of reducing equivalents produced by oxidation of sorbitol by 
sorbitol dehydrogenase into the mitochondria via the malate- 
aspartate shuttle, resulting in inhibition of gluconeogenesis 
from sorbitol(4). Thus, the greater the capacity of the malate- 
aspartate shuttle, the smaller the inhibition of glucose syn- 
thesis by ethanol. For example, in livers from normal rats, 
ethanol inhibited glucose production from sorbitol about 50% 
(3); however, if rats were exposed to cold for 3-6 weeks, 
ethanol failed to inhibit glucose formation. From such exper- 
iments it was concluded that the capacity of the malate- 
aspartate shuttle was increased by cold exposure (3). 
It is well known that the mitochondrial inner membrane is 
impermeable to pyridine nucleotides (1); thus, a number of 
hydrogen shuttle mechanisms have been suggested to account 
for the bidirectional transport of reducing equivalents be- 
tween the cytosol and mitochondria. One of the first proposals 
was the malate shuttle of Borst (2). NADH produced in the 
cytosol from the oxidation of ethanol converts cytosolic ox- 
alacetate into malate via malate dehydrogenase which enters 
mitochondria in exchange for a-ketoglutarate (see Fig. 5). 
Once inside the mitochondria, malate is converted into oxal- 
acetate, resulting in the regeneration of NADH. Subsequently, 
Reoxidation of NADH is believed to be a major rate- 
determining step in hepatic ethanol oxidation (for review, see 
5). Reducing equivalents generated from the metabolism of 
ethanol via alcohol dehydrogenase are moved into mitochon- 
dria predominantly by the malate-aspartate shuttle (6), which 
has led to the hypothesis that shuttle capacity is also an 
important rate determinant for ethanol metabolism (7). It is 
well established that ethanol treatment stimulates ethanol 
oxidation (8, 9); however, whether associated changes in the 
capacity of the malate-aspartate shuttle occur has not been 
established clearly. Therefore, the purpose of the present 
study was to assess the effect of acute and chronic treatment 
of rats with ethanol on the capacity of the malate-aspartate 
shuttle in the perfused rat liver where complications caused 
by cell isolation are avoided. The results indicate that shuttle 
capacity is indeed increased dramatically by ethanol. 
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group received a solution of 25% sucrose containing 35% ethanol for
3-5 weeks (10).
Liver Perfusion-The nonrecirculating liver perfusion system used
has been described in detail elsewhere (11). The perfusion fluid was
Krebs-Henseleit bicarbonate buffer, pH 7.4, 37 "C, saturated with
02:C02 (19:1). Oxygen uptake was calculated from influent minus
effluent oxygen concentration differences measured with a Clark-
type electrode (11), and fluorescence of pyridine nucleotides (excita-
tion at 366 nm, emission at 450 nm) from the surface of the liver was
monitored as described previously (12).
Analytical-Samples of perfusate were collected at 2-5-min inter-
vals for analysis of glucose, lactate, pyruvate, and ethanol by standard
enzymatic procedures (13). Rates were calculated from influent minus
effluent concentration differences, flow rates, and liver wet weights.
Statistical comparisons were performed with Student's t test (14).
RESULTS
Effect of Acute Ethanol Treatment on Ethanol Uptake and
Flux ouerthe Malate-Aspartate Shuttle-Basal rates of oxygen
uptake by livers from normal, fed rats were around 120 ~mol/
g/h; rates were elevated to around 180 ~mol/g/h in livers from
rats treated 2.5 h before surgery with ethanol (SIAM) (Fig. 1,
A and B). Infusion of the transaminase inhibitor aminooxy-
acetate (0.2 mM) decreased O2 uptake 20-30 ~mol/g/h in both
groups (Fig. 1, A and B; Fig. 2). Concomitantly, pyridine
nucleotide fluorescence detected from the surface of the liver
increased transiently in livers from normal rats whereas the
elevation was sustained in livers from SIAM rats (Fig. 1, A
and B, top panels). When ethanol (2 mM) was infused, oxygen
uptake increased about 15 ~mol/g/h in livers from both groups
(Figs. 1 and 2). Pyridine nucleotide fluorescence in livers from
control rats was increased about 25% of the maximal response
to anoxia produced by infusion of perfusate saturated with
N2; however, fluorescence was increased about 40% of the
anoxic response in livers from SIAM rats (Fig. 1, A and B,
top panels). When ethanol infusion was terminated, oxygen




FIG. 1. Effects of aminooxyacetate and ethanol on oxygen
uptake and pyridine nucleotide fluorescence in perfused livers
from normal and acutely ethanol-treated (SIAM) rats. Livers
from fed control or SIAM rats were perfused in a nonrecirculating
system as described under "Experimental Procedures." Oxygen up-
take was measured with a Clark-type platinum electrode, and pyridine
nucleotide fluorescence (366-450 nm) was monitored from the surface
of the liver with a large tipped light guide. Aminooxyacetate (ADA,
0.2 mM) and ethanol (EtOH, 2 mM) were infused as noted by the
horizontal bars and vertical arrows. Perfusate was saturated with a
19:1 mixture of N2:C02 as indicated by the vertical arrows and
horizontal bars. A, liver from a saline-treated rat. B, liver from a rat
treated with ethanol (5.0 g/kg i.g.) 2.5 h before perfusion. Experiments
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FIG. 2. Effects of aminooxyacetate and ethanol on rates of
oxygen uptake and lactate production in livers from control
and SIAM rats. Livers from fed control and SIAM rats were
perfused as described under "Experimental Procedures," and rates of
oxygen uptake and lactate production were measured as described in
the legend to Fig. 1 and under "Experimental Procedures." Data
represent mean ± S.E. for five livers/group. Open boxes, no additions;
hatched boxes, rates in the presence of aminooxyacetate (0.2 mM);
filled boxes, rates in the presence of aminooxyacetate plus ethanol (2
mM). Left panel, rates of oxygen uptake. Right panel, rates of lactate
production. *, p < 0.05 as compared with basal values.
ished to basal levels in both groups of livers. After the infusion
of aminooxyacetate was terminated, oxygen uptake increased
to basal values whereas pyridine nucleotide fluorescence did
not change.
Basal rates of lactate production of around 60 /Lmol/g/h in
livers from control rats were diminished to about 25 ~mol/g/
h after acute exposure to ethanol 2.5 h before perfusion in
livers from SIAM rats (Fig. 2) due to depletion of glycogen
stores by ethanol (19). Upon infusion of aminooxyacetate,
lactate production increased significantly to 95 ± 12 ~mol/g/
h in control livers but was unaffected in livers from SIAM
rats. This increase in livers from control rats was due most
likely to elevated rates of conversion of pyruvate to lactate
via lactate dehydrogenase caused by an increase in NADH
redox state following infusion of aminooxyacetate. Glycolysis
then increased because of the concomitant oxidation of
NADH to NAD+ available for glyceraldehyde-3-phosphate
dehydrogenase. When ethanol was infused subsequently, lac-
tate production decreased dramatically in livers from control
rats to about 20 JLmol/g/h (Fig. 2). Rates were also diminished
in livers from SIAM rats, but the absolute decrease was only
around 10 ~mol/g/h because glycogen stores were depleted by
prior administration of ethanol (19, 20), and thus rates of
glycolysis were minimal.
Flux over the malate-aspartate shuttle was evaluated by
measuring the degree of inhibition of glucose production from
the reduced substrate sorbitol by ethanol as described in detail
elsewhere by Sugano et al. (3). Results of a typical experiment
are shown in Fig. 3. The infusion of sorbitol (5 mM) increased
rates of glucose production in livers from fasted rats signifi-
cantly to 29 ± 2 JLmol/g/h. The subsequent infusion of alanine
(0.3 mM) increased rates of glucose formation to about 45
~mol/g/h by providing oxalacetate for the malate-aspartate
shuttle and elevated oxygen uptake 10 ~mol/g/h to values of
around 110 ~mol/g/h. Alanine alone at concentrations up to
2.5 mM only increased rates of glucose production about 3-4
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aspartate shuttle was assessed by employing the experimental
design depicted in Fig. 3. In the presence of 1.2 mM alanine,
rates of glucose formation from sorbitol in livers from sucrose-
treated rats were diminished by ethanol to about 40% of
values measured in the absence of ethanol (Fig. 4, right, open
bar). In contrast, infusion of ethanol inhibited glucose pro-
duction by only around 4% in livers from ethanol-treated rats
(Fig. 4, right, solid bar). Rates of ethanol uptake were elevated
significantly from 71 ± 6 to 222 ± 15 Ilmol/g/h (n = 5, p <
0.01) by chronic ethanol treatment. Under these conditions,
ethanol uptake was inhibited 90% by aminooxyacetate to 7 ±
2 Ilmol/g/h in livers from control rats and 75% (to 50 ± 4




FIG. 4. Effect of ethanol on glucose production from sorbitol
in the presence of alanine in perfused livers from control or
ethanol-treated rats. Livers were perfused in a nonrecirculating
system as typified in Fig. 3, and sorbitol (5 mM), alanine (1.2 mM),
and ethanol (2 mM) were infused. Rates of glucose production were
measured enzymatically as described under "Experimental Proce-
dures." Left, effects of ethanol on glucose production by livers from
saline-treated (control, open box) or acutely ethanol-treated rats
(treated, filled box). Control rates were 52 ± 2 and 49 ± 3/lmol/g/h,
respectively. Right, effects of ethanol on glucose production by livers
from sucrose-treated (control, open box) or chronically ethanol-
treated rats (treated, filled box). Control rates were 39 ± 2 and 41 ±
2 /lmol/g/h, respectively. " p < 0.05; ", p < 0.01 as compared with

























Acute Treatment with Ethanol Increases Malate-Aspartate
Shuttle Capacity-The malate-aspartate shuttle utilizes re-
ducing equivalents generated in the cytosol to convert oxala-
cetate to malate via malate dehydrogenase (see Fig. 5). Malate
is then transported into the mitochondria in exchange for ex-
ketoglutarate. The process is reversed in the mitochondria
when malate dehydrogenase converts malate into oxalacetate
and NADH, and the latter is reoxidized to NAD+ with the
concomitant consumption of oxygen. Carbon flow is balanced
by transamination of mitochondrial oxalacetate to aspartate,
which is transported into the cytosol in exchange for gluta-
mate (Fig. 5).
Sugano et al. (3) demonstrated that the capacity of the
malate-aspartate substrate shuttle system to move reducing
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~mol/g/h.l Thus, the effect of alanine is catalytic and cannot
be ascribed to its conversion directly to glucose. Ethanol (2
mM) decreased glucose production nearly completely and,
after elevating oxygen uptake transiently, diminished rates
about 10 Ilmol/g/h (Fig. 3, upper panel). When infusion of
ethanol was terminated, rates of glucose production and oxy-
gen uptake returned to basal values. Because it was possible
that intermediates for the malate-aspartate shuttle could still
be rate limiting in livers from fasted rats even in the presence
of 0.3 mMalanine, the concentration of alanine was elevated.
Upon infusion of 1.2 mM alanine, maximal rates of glucose
production were still around 50 Ilmol/g/h (i.e. higher concen-
trations of alanine did not stimulate glucose synthesis), and
oxygen uptake was elevated to values around 140 Ilmol/g/h
(Fig. 3). Upon infusion of ethanol, rates of glucose production
were inhibited to about 45% of control values in livers from
normal rats (Figs. 3 and 4). In contrast, rates of glucose
formation were diminished only to about 75% of control in
livers from ethanol-treated (SIAM) rats (Fig. 4, left, solid bar).
Under these conditions, rates of ethanol uptake were signifi-
cantly higher in livers from SIAM than control rats (92 ± 7
versus 69 ± 7 Ilmol/g/h, n = 5, p < 0.05).
Effect of Chronic Treatment with Ethanol on Malate-Aspar-
tate Shuttle Capacity in Perfused Rat Liver-The effect of
chronic treatment with ethanol on flux over the malate-
Minutes of PerfusIon
FIG. 3. Effects of sorbitol, alanine, and ethanol on oxygen
uptake and glucose production in a perfused rat liver. A liver
from a fasted rat treated with 25% sucrose in the drinking water for
6 weeks was perfused, and rates of oxygen uptake and glucose pro-
duction were measured as described under "Experimental Proce-
dures." Sorbitol (5 mM),alanine (0.3 or 1.2 mu), and ethanol (EtOH,
2 mM) were infused as noted by the horizontal bars and vertical
arrows. The experiment is typical of five livers.
FIG. 5. Mechanism of movement of reducing equivalents
from the cytosol into mitochondria by the malate-aspartate
shuttle. Sorbitol or ethanol is oxidized by cytosolic dehydrogenases
with the concomitant formation of fructose or acetaldehyde, respec-
tively, and reduction of NAD+to NADH. Malate dehydrogenase then
reduces oxalacetate (OM) to malate (MAL), and NADH is oxidized
to NAD+. Malate is transported into the mitochondria in exchange
for a-ketoglutarate (aKG). Mitochondrial malate is then oxidized to
oxalacetate via malate dehydrogenase, and NAD+ is reduced to
NADH, which is then reoxidized via the electron transport chain
with consumption of molecular oxygen. Mitochondrial oxalacetate is
transaminated to aspartate (ASP) with the concomitant deamination
of glutamate (GLUT) to a-ketoglutarate, and aspartate is transported
from mitochondria into the cytosol by a Ca2+-sensitive translocator
in exchange for glutamate. The transamination of aspartate to oxal-
acetate and a-ketoglutarate to glutamate is inhibited by aminooxy-
acetate (ADA). Mitochondrial oxalacetate can also be formed by the
deamination of alanine to pyruvate and carboxylation of pyruvate
into oxalacetate.
be assessed qualitatively by measuring the effects of ethanol
on rates of glucose synthesis from a reduced substrate ti.e.
sorbitol) in the presence of catalytic amounts of alanine which
generate oxalacetate in the mitochondria (see Fig. 5). Infusion
of ethanol increases the generation of reducing equivalents in
the cytosol via alcohol dehydrogenase, which competes for
movement of NADH produced by the oxidation of sorbitol
via sorbitol dehydrogenase through the malate-aspartate shut-
tle into the mitochondria and thus inhibits glucose synthesis.
However, if malate-aspartate shuttle capacity is increased,
such as in livers from cold-adapted rats (3), the capacity to
move hydrogen from NADH from the cytosol into mitochon-
dria is increased, and thus inhibition of glucose synthesis
from sorbitol by ethanol is diminished.
Pretreatment for 3-4 h with ethanol causes a swift increase
in alcohol metabolism (SIAM) in rats (15; see "Results"),
mice (16), ADH-positive deermice (17) and humans (18). The
mechanism of SIAM involves more rapid reoxidation of
NADH to NAD+ in mitochondria due to relatively increased
rates of ADP production as a result of decreased glycolysis
(19). Since reoxidation of NADH is postulated to be rate
limiting for ethanol oxidation via ADH, it is likely that
malate-aspartate shuttle capacity is increased by acute
ethanol treatment. Indeed, four observations support this
idea. First, rates of oxygen uptake were elevated about 50%
by acute ethanol treatment (Figs. 1and 2 and Ref. 19). Second,
increases in NADH fluorescence caused by ethanol in the
presence of the transaminase inhibitor aminooxyacetate were
about twice as great in livers from SIAM rats as in livers from
controls (Figs. 1 and 2). Third, rates of export of reducing
equivalents in the form of lactate were not increased by
infusion of aminooxyacetate in livers from SIAM animals
(Fig. 3, right panel). In contrast, lactate production was ele-
vated significantly by inhibition of transaminases in livers
from control rats, indicating increased export of reducing
equivalents as lactate under these conditions. Fourth, glucose
production from sorbitol was inhibited much less in livers
from ethanol-treated (SIAM) rats than in controls (Fig. 4),
indicating that competition for movement of reducing equiv-
alents generated by oxidation of ethanol and sorbitol dehy-
drogenase into mitochondria was diminished. Taken together,
these data indicate that malate-aspartate shuttle capacity is
increased by acute treatment with ethanol.
Movement of NADH from Cytosol into Mitochondria via the
Malate-Aspartate Shuttle Is an Important Rate Determinant
of Hepatic Ethanol Oxidation-It is well documented that
chronic treatment with ethanol increases rates of hepatic
ethanol oxidation (8, 9). In the present study, rates of ethanol
uptake were elevated by chronic treatment with ethanol and
were inhibited almost completely by the transaminase inhib-
itor, aminooxyacetate (see "Results"), consistent with other
observations that ethanol elimination in vivo was decreased
significantly by the inhibitor (21). These data are consistent
with the hypothesis that reoxidation of NADH to NAD+ in
mitochondria via the malate-aspartate shuttle is a key rate
determinant in ethanol oxidation in perfused rat liver. It also
indicates that flux of reducing equivalents over the malate-
aspartate shuttle is increased after chronic treatment with
ethanol. In support of this latter idea, glucoseproduction from
sorbitol was unaffected by infusion of ethanol in perfused
livers from ethanol-treated rats (Fig. 4, right, solid bar). In
contrast, rates were diminished more than 50% in livers from
control rats (Fig. 4, right, open bar), indicating a greater
capacity to move reducing equivalents between the cytosol
and the mitochondria in livers from chronically ethanol-
treated rats than in untreated controls. Moreover, rates of
ethanol oxidation were more rapid in livers from chronically
treated rats where flux over the malate-aspartate shuttle was
greater than in livers from rats treated acutely with ethanol
(Fig. 4 and "Results"), lending further support to the hypoth-
esis that movement of reducing equivalents from cytosol into
mitochondria via the malate-aspartate shuttle is a key rate
determinant of hepatic ethanol metabolism.
How Does Ethanol Treatment Increase Malate-Aspartate
Shuttle Capacity?-The data presented in this study clearly
demonstrate that both acute and chronic treatments with
ethanol elevate hepatic malate-aspartate shuttle capacity;
however, the mechanism by which this occurs is not yet clear.
It is well known that ethanol elevates blood levels of adrener-
gic hormones such as epinephrine and norepinephrine (20).
In addition, norepinephrine increases malate-aspartate shut-
tle capacity in perfused livers (22), most likely by increasing
levels of mitochondrial Ca2+ which stimulates aspartate efflux
from mitochondria via the glutamate-aspartate translocator
(23). The resultant elevation in cytosolic aspartate would in
turn increase the capacity of the malate-aspartate shuttle by
elevating levels of cytosolic oxalacetate. Also, rates of ethanol
oxidation and malate-aspartate shuttle capacity are elevated
in livers from cold-adapted rats due to increased circulating
levels of adrenergic hormones (3). Further, increases in oxy-
gen uptake and ethanol metabolism in perfused rat livers
caused by acute treatment with ethanol are blocked by adre-
nalectomy (19). Taken together, these data indicate that
malate-aspartate shuttle capacity is elevated by ethanol due
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to hormone-mediated increases in Ca2+ levels which stimulate
aspartate efflux from mitochondria. Thus, the malate-aspar-
tate shuttle is an important rate determinant in hepatic
ethanol metabolism. It follows from this reasoning that nu-
tritional and hormonal factors that affect hepatic intracellular
calcium will influence ethanol metabolism via actions on the
malate-aspartate shuttle.
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